FG-3019, a human monoclonal antibody to CTGF, with gemcitabine/erlotinib in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma.
Vincent J. Picozzi
Research Funding - FibroGen
J. Marc Pipas
Research Funding - FibroGen
Albert Koong
Research Funding - FibroGen
Amato Giaccia
Consultant or Advisory Role - FibroGen; FibroGen
Nathan Bahary
Research Funding - FibroGen
Smitha S. Krishnamurthi
Research Funding - FibroGen
Charles D. Lopez
Research Funding - FibroGen
Peter J. O'Dwyer
Research Funding - FibroGen
Katharina Modelska
Employment or Leadership Position - FibroGen
Stock Ownership - FibroGen
Vanessa Poolman
Employment or Leadership Position - FibroGen
Stock Ownership - FibroGen
James Chou
Employment or Leadership Position - FibroGen
Stock Ownership - FibroGen
Ming Zhong
Employment or Leadership Position - FibroGen
Stock Ownership - FibroGen
Seth Porter
Employment or Leadership Position - FibroGen
Stock Ownership - FibroGen
Tom Neff
Employment or Leadership Position - FibroGen
Stock Ownership - FibroGen
Frank Valone
Employment or Leadership Position - FibroGen
Stock Ownership - FibroGen